Volume 19(1); 2024 Feb
Articles from this journal are generally available in PMC after a 12-month delay (embargo); however, the delay may vary at the discretion of the publisher.
Expert Discussion
Interview ABC7: Bridging the Gap
Rachel Wuerstlein, Maria João Cardoso, Joana M. Ribeiro, Renate Haidinger, Volkmar Müller, Matteo Lambertini, Eva Schumacher-Wulf
Breast Care (Basel) 2024 Feb; 19(1): 77–83. Published online 2023 Dec 16. doi: 10.1159/000535632
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedNovel Insights from Clinical Practice
Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants
Kerstin Riecke, Lisa Steinhilper, Charlotte von Bülow, Dorothee Schwarz, Eike Burandt, Jana Käthe Striefler, Volkmar Müller, Barbara Schmalfeldt, Isabell Witzel
Breast Care (Basel) 2024 Feb; 19(1): 73–76. Published online 2023 Sep 30. doi: 10.1159/000534367
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedResearch Articles
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study
Nadia Harbeck, Denise Wrobel, Matthias Zaiss, Jürgen Terhaag, Dagmar Guth, Andrea Distelrath, Mark-Oliver Zahn, Rachel Wuerstlein, Andreas Lorenz, Rupert Bartsch, Urs Breitenstein, Michael Schwitter, Marija Balic, Christian Jackisch, Volkmar Müller, Gabriel Rinnerthaler, Marcus Schmidt, Khalil Zaman, Timo Schinköthe, Anna Resch, Roberta Valenti, Diana Lüftner
Breast Care (Basel) 2024 Feb; 19(1): 1–9. Published online 2023 Oct 5. doi: 10.1159/000533657
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedReimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences
Constantin Pixberg, Markus Schulze, Lars Buschhorn, Jan Philip Suppelna, Andreas Mock, Mario Hlevnjak, Sabine Heublein, Eva Schumacher-Wulf, Andreas Schneeweiss
Breast Care (Basel) 2024 Feb; 19(1): 10–17. Published online 2023 Sep 20. doi: 10.1159/000533902
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedStrict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience
Israel Barco, Marc García-Font, Antonio García-Fdez, Manel Fraile, Elena Vallejo, MCarmen Vidal, Sonia González, Clarisa González, Claudia Beatriz Mitru, Oriol Porta, Carolina Chabrera Sanz
Breast Care (Basel) 2024 Feb; 19(1): 18–26. Published online 2023 Sep 16. doi: 10.1159/000533731
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedBudget Impact of the Oncotype DX Breast Recurrence Score® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany
Michael Patrick Lux, Christof Minartz, Harald Müller-Huesmann, Marianar Felicia Sandor, Sabine Radeck-Knorre, Aljoscha Steffen Neubauer
Breast Care (Basel) 2024 Feb; 19(1): 27–33. Published online 2023 Dec 5. doi: 10.1159/000534096
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedUse of the Gene Expression Test Prosigna® in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67
Cordula Ziegler, Karl Sotlar, Daniel Maria Hofmann, Thomas Kolben, Nadia Harbeck, Rachel Wuerstlein
Breast Care (Basel) 2024 Feb; 19(1): 34–42. Published online 2023 Oct 17. doi: 10.1159/000534634
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedThe Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study
Xin Zhang, Chao Wang, Jialin Fan, Shinichiro Murakami, Hualong Xie, Ming Huo
Breast Care (Basel) 2024 Feb; 19(1): 43–48. Published online 2023 Nov 9. doi: 10.1159/000535063
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedFinal Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting
Thomas Decker, Matthias Zaiss, Dunja Klein, Antje Hahn, Volker Hagen, Paul La Rosée, Rüdiger Liersch, Thomas Wolff, Beate Niemeier, Larissa E. Hillebrand, Carolin Lennartz, Marco Chiabudini, Fee Bengsch, Martin Indorf, Norbert Marschner
Breast Care (Basel) 2024 Feb; 19(1): 49–61. Published online 2023 Dec 20. doi: 10.1159/000535135
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMedLong-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection
Constanze Elfgen, Zsuzsanna Varga, Katrin Breitling, Eliane Pauli, Daniela Schwegler-Guggemos, Gert Kampmann, Rahel A. Kubik-Huch, Cornelia Leo, Domenico Lepori, Martin Sonnenschein, Christoph Tausch, Simone Schrading
Breast Care (Basel) 2024 Feb; 19(1): 62–72. Published online 2023 Sep 7. doi: 10.1159/000533673
Currently embargoed: Free in PMC on Feb 1, 2025;
PubMed
Articles from Breast Care are provided here courtesy of Karger Publishers